Mechanisms of viral entry: sneaking in the front doorIdentification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNRScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IFunctional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoproteinBinding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infectionHighly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered EntrySubcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virusEfficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell CultureCell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitroPersistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and HostDiverse CD81 Proteins Support Hepatitis C Virus InfectionHepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particlesExpression of DC-SIGN and DC-SIGNR on Human Sinusoidal EndotheliumSuperinfection Exclusion in Cells Infected with Hepatitis C VirusThe Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope ProteinEffect of Cell Polarization on Hepatitis C Virus EntrySerum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 DependentCD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus EntryProtein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and InfectivityIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesIn vitro selection of a neutralization-resistant hepatitis C virus escape mutantHepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cellsMutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus InfectivityPolarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma CellsHepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCVHepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus InternalizationIdentification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variantsAn alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmissionComplete replication of hepatitis C virus in cell cultureSolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesClaudin-1 is a hepatitis C virus co-receptor required for a late step in entryNaturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralizationBinding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.Claudin association with CD81 defines hepatitis C virus entry.Hepatitis C virus induces CD81 and claudin-1 endocytosis.Rituximab treatment in hepatitis C infection: an in vitro model to study the impact of B cell depletion on virus infectivity.Production, purification and characterization of recombinant, full-length human claudin-1.
P50
Q22252690-8DA52B41-2C73-421B-B8EC-FE548CF7A8B6Q24524809-1F991B56-69A4-428B-B353-6231D8D4A5C1Q24551041-6E14ABF1-3B56-4F7A-8592-2A1EB1B5E0A1Q24672232-D3A5DF6B-1AFA-4CBB-A232-90A60D697A02Q24676039-5508580A-F13E-4791-936F-DB2B8405D774Q27469621-0203D51C-AD27-45DB-BB83-040A4BADD99CQ27469669-7FF45155-0F17-4BB1-A6D2-A7DB89F42CA4Q27472912-99B665E3-1B8A-47D5-93D4-C815089EF50DQ27472926-9AC0C97B-AB6B-4329-8113-5B6E65C29587Q27473047-F0E3824C-AE24-4CEE-BF70-DBCDF1C229E5Q27473339-EC703962-6318-4F3C-A564-7380F362B5DAQ27473436-CBD70206-3F1C-4533-9AA2-58D46E13587AQ27477623-5AAE70E5-AA0D-4C36-A546-FA040CA4C05AQ27477625-FE42E4CF-8928-46B8-A3E2-48B3E1A8F36DQ27477687-FBD3DA3D-D7DA-4711-AAE7-FA05D725290CQ27477777-09B1DA1D-A8A7-4B45-83DE-3EA3EC0A3B17Q27478378-34837992-CAA8-4A54-9F11-A223C489CBC6Q27481009-5ABF95F2-FC30-4945-83BA-000C404DF731Q27485293-B83C575F-8882-49F2-8373-F9156CA82B50Q27485298-2DE6D3FC-3D5B-4348-AAC7-424949588AF4Q27485899-8EBE2B0D-9C90-4150-AEB6-C17185971199Q27486784-317AD8BA-FE81-495A-95A1-438285BD33D4Q27487399-5BDF3AAD-21AB-4B2D-AD73-09DD047B7DFAQ27487549-755BF120-B468-4714-9F2B-6DC6B0320890Q27487754-82FE450A-88D0-45FA-812F-A5542A69F8FEQ27488430-ED26F461-D8FC-45E4-9A96-E6AA226B6BCEQ27488433-42EDF10A-F6AC-46DF-9418-53CF5A8CB35AQ27488816-EBE84A0A-01F2-4AD2-B13E-C451DD8D3783Q27490466-731D03F9-BFD5-427B-B9CF-2B097B1E1C60Q27618367-22BCAFFF-1695-49F4-BF83-22604F461EC4Q27684354-75EC3FE0-93CD-4FC1-9756-EF5AA39404C5Q27860934-12EA642F-AFC5-4FFB-BEDD-9EB28F7C9BABQ27928046-BB30376E-8ED5-4D56-AF5F-73A287D804F4Q28131832-3B842B3B-6DC8-4944-929B-111E59FE8DE0Q28731355-213B4049-E950-4E3D-988D-AFD9462CF964Q29048140-FFE679B1-166F-47A3-821C-EC801DBD8776Q29465808-0E44D1E6-0CC6-46B6-BDAD-1C4A7C90627DQ30512696-9A3F5D33-ABF9-4D82-B46D-DC1EE36744DAQ31032919-DB11B090-5187-4728-A602-912AC7C3C56CQ31118101-81E53FBB-59EE-4DB4-A235-74BA979E6259
P50
description
British virologist
@en
British virologist
@en-ca
British virologist
@en-gb
viróloga británica
@es
عالمة فيروسات بريطانية
@ar
name
Jane A. McKeating
@en
Jane A. McKeating
@nl
Jane A. McKeating
@sl
Jane McKeating
@ca
Jane McKeating
@es
Jane McKeating
@fr
type
label
Jane A. McKeating
@en
Jane A. McKeating
@nl
Jane A. McKeating
@sl
Jane McKeating
@ca
Jane McKeating
@es
Jane McKeating
@fr
altLabel
Jane McKeating
@en
prefLabel
Jane A. McKeating
@en
Jane A. McKeating
@nl
Jane A. McKeating
@sl
Jane McKeating
@ca
Jane McKeating
@es
Jane McKeating
@fr
P106
P1153
35495802400
P1960
kfF_62MAAAAJ
P21
P31
P496
0000-0002-7229-5886
P569
2000-01-01T00:00:00Z